Cargando…
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
INTRODUCTION: The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021. AIM: We aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory i...
Ejemplares similares
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
por: Rose, Angela MC, et al.
Publicado: (2023) -
Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019
por: Subissi, Lorenzo, et al.
Publicado: (2021) -
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study
por: Fischer, Natalie, et al.
Publicado: (2021) -
Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019–2020 influenza season: a test negative case – control study
por: Vaikutyte, Roberta, et al.
Publicado: (2023) -
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020
por: Fischer, Natalie, et al.
Publicado: (2023)